Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update
Top Cited Papers
Open Access
- 1 August 2014
- journal article
- research article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 35 (S1), s1-s67
- https://doi.org/10.1086/676882
Abstract
The 2013 Infection Prevention and Control (IP&C) Guideline for Cystic Fibrosis (CF) was commissioned by the CF Foundation as an update of the 2003 Infection Control Guideline for CF. During the past decade, new knowledge and new challenges provided the following rationale to develop updated IP&C strategies for this unique population:1.The need to integrate relevant recommendations from evidence-based guidelines published since 2003 into IP&C practices for CF. These included guidelines from the Centers for Disease Control and Prevention (CDC)/Healthcare Infection Control Practices Advisory Committee (HICPAC), the World Health Organization (WHO), and key professional societies, including the Infectious Diseases Society of America (IDSA) and the Society for Healthcare Epidemiology of America (SHEA). During the past decade, new evidence has led to a renewed emphasis on source containment of potential pathogens and the role played by the contaminated healthcare environment in the transmission of infectious agents. Furthermore, an increased understanding of the importance of the application of implementation science, monitoring adherence, and feedback principles has been shown to increase the effectiveness of IP&C guideline recommendations.2.Experience with emerging pathogens in the non-CF population has expanded our understanding of droplet transmission of respiratory pathogens and can inform IP&C strategies for CF. These pathogens include severe acute respiratory syndrome coronavirus and the 2009 influenza A H1N1. Lessons learned about preventing transmission of methicillin-resistantStaphylococcus aureus(MRSA) and multidrug-resistant gram-negative pathogens in non-CF patient populations also can inform IP&C strategies for CF.Keywords
This publication has 302 references indexed in Scilit:
- Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort studyThe Lancet, 2013
- Whole-genome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: a descriptive studyThe Lancet Infectious Diseases, 2013
- Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosisJournal of Cystic Fibrosis, 2012
- Prostatic abscess in a pediatric patient with chronic granulomatous disease: report of a unique case and review of the literatureJournal of Pediatric Surgery, 2012
- The impact of household transmission on duration of outpatient colonization with methicillin-resistantStaphylococcus aureusEpidemiology and Infection, 2010
- Cell phone intervention to improve adherence: Cystic fibrosis care team, patient, and parent perspectivesPediatric Pulmonology, 2010
- Adverse outcomes associated with contact precautions: A review of the literatureAmerican Journal of Infection Control, 2009
- 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care SettingsAmerican Journal of Infection Control, 2007
- Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infectionsNature Reviews Microbiology, 2006
- Why Don't Physicians Follow Clinical Practice Guidelines?JAMA, 1999